Neurology in Rocky Point, NY
3 verified neurology doctors in Rocky Point.
Neurologists diagnose and treat disorders of the brain, spinal cord, and nervous system, such as migraines, epilepsy, and stroke.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the New York State Board for Professional Medical Conduct
Dr. Scott Mcwilliams, MD
Neurology
CMS Open Payments· $1,607 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,607
Total received
80
Transactions
25
Paying companies
Top paying companies
Among the 22,669 neurology doctors we've analyzed, about 51% received any industry payment (median $640 among those who did). This doctor's total ranks around the 81th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US neurology doctors.
Payments to Scott Mcwilliams do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Augustine Romano, MD
Neurology
CMS Open Payments· $3,406 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$3,406
Total received
169
Transactions
35
Paying companies
Top paying companies
Among the 22,669 neurology doctors we've analyzed, about 51% received any industry payment (median $640 among those who did). This doctor's total ranks around the 86th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US neurology doctors.
Payments to Augustine Romano do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Rebecca Monastero, MD
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.